Delivery Order SPE2DB22D1106-SPE2DB24FFKZ7

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $1,304.72 and a completion date of August 15, 2024. This contract is not set aside for any specific business type. AmerisourceBergen has been awarded numerous federal contracts by defense and civilian...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Ondansetron HCL 8 mg Tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $1,839.70 and an ultimate completion date of September 3, 2024. It is a firm-fixed-price contract, which indicates a pre-determined price for the supplies. The contract is not designated as a set-aside....
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ondansetron hydrochloride 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $6,423.40 and a period of performance through June 4, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price of $1,503.07 and an ultimate completion date of August 13, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, through its Corporate Office division, has...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a Firm Fixed Price pricing type and a Ceiling Value of $17,453.56. It was awarded on April 7, 2025, with an Ultimate Completion Date of April 8, 2025. The contract is not designated as a Set-Aside. AmerisourceBergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron HCL 4 mg tablets, a pharmaceutical product used to treat nausea and vomiting. The contract has a ceiling value of $24,582.83 and a completion date of July 3, 2025. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen Drug Corp is the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,828,704 units of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $19,733.40 and a completion date of April 8, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $2,873.75 and a completion date of February 10, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,958,111 units of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a Firm Fixed Price pricing type and a total ceiling value of $17,185.18. It is not set aside for any specific type of business. The contract has an ultimate...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $8,204.58 and runs through March 4, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFKZ7
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $22,584.93 and a completion date of September 5, 2024. It is a firm fixed-price contract, meaning the price will not change regardless of the contractor's actual costs. This contract is not set aside for any specific business type. Amerisourcebergen, through its Corporate Office division, has extensive experience supplying pharmaceutical products and medical supplies to various federal agencies, including the DLA, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 12/4/24, 9:51 AM